In vitro evaluation of newly synthesised [1,2,4]triazolo[1,5a]pyrimidine derivatives against Trypanosoma cruzi, Leishmania donovani and Phytomonas staheli.
The antiprotozoal activity of newly synthesised compounds, all [1,2,4]triazolo [1,5a]pyrimidine derivatives, was tested against the protozoan parasites Trypanosoma cruzi, Leishmania donovani and Phytotmonas staheli. Six of these compounds significantly inhibited in vitro cell growth of the epimastigote forms of T. cruzi, and the promastigote forms of L. donovani and P. staheli. Some of the compounds reached complete growth inhibition at 1 microg/ml for 48 h of parasite/drug interaction. None of the compounds tested showed significant toxicity against cells of Aedes albopictus, mouse macrophages J-774A.1 and Lycopersicum esculentum at dosages five times greater than used against parasites.
Luque
F
F
Instituto de Biotecnología, Grupo de Bioquímica y Parasitología Molecular ,Facultad de Ciencias, Universidad de Granada, Spain.
Fernández-Ramos
C
C
Entrala
E
E
Rosales
M J
MJ
Navarro
J A
JA
Romero
M A
MA
Salas
J M
JM
Sánchez-Moreno
M
M
D000330:Aedes / Q000469:parasitology; D000818:Animals; D000977:Antiparasitic Agents / Q000494:pharmacology*; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D066298:In Vitro Techniques; D007893:Leishmania donovani / Q000187:drug effects*; D018551:Solanum lycopersicum / Q000166:cytology / Q000469:parasitology; D008264:Macrophages / Q000469:parasitology; D051379:Mice; D011743:Pyrimidines / Q000494:pharmacology*; D014349:Trypanosoma cruzi / Q000187:drug effects* / Q000502:physiology
D000977:Antiparasitic Agents; D011743:Pyrimidines